United Kingdom

Yabao Pharmaceutical Group Co Ltd (600351.SS)

600351.SS on Shanghai Stock Exchange

15 Dec 2017
Change (% chg)

¥0.02 (+0.27%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the... (more)


Beta: 0.78
Market Cap(Mil.): ¥6,217.63
Shares Outstanding(Mil.): 787.04
Dividend: 0.02
Yield (%): 0.25


  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Yabao Pharma's controlling shareholder plans exchangeable bonds issue

* Says controlling shareholder plans to raise up to 500 million yuan ($75.33 million) in exchangeable bonds issue

10 Nov 2017

BRIEF-Yabao Pharmaceutical Group gets approval to conduct drug clinical trials for diabetes

* Says it gets an approval to conduct drug clinical trials of SY-008 which can be used for treatment of diabetes, from China Food and Drug Administration

31 Jul 2017

BRIEF-Yabao Pharmaceutical Group says dividend payment date on June 30

* Says it will pay cash dividend of 0.02 yuan per share (before tax) for FY 2016 to shareholders of record on June 29

26 Jun 2017

Earnings vs. Estimates